Humanetics Corporation Alternatives & Competitors

12 companies similar to Humanetics Corporation — Preventing Radiation Damage

Aston Sci.

Empowering Patients with Innovative Cancer Immunotherapy

8 Series C $27.00B

Korea South

Biotechnology Pharmaceutical

Antengene

Treating Patients Beyond Borders.

69 Series C $238.00M

Shanghai, China

Biopharma Biotechnology +2

Aegera Therapeutics Inc.

6 Debt Financing $38.00M

Biotechnology Health Care +1

Moleculin Biotech, Inc.

Groundbreaking Cancer Therapies

22 Post-IPO Equity

Houston, United States

Biotechnology Pharmaceutical

Track all Humanetics Corporation competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Cantex Pharmaceuticals, Inc.

Developing novel treatments of inflammatory diseases and cancer

3 Debt Financing $22.27M

Biopharma Biotechnology +1

Prescient Therapeutics

A clinical stage oncology company developing personalised medicine approaches to cancer; c...

14 Post-IPO Equity $3.00M

Australia

Biopharma Biotechnology +3

Candid Therapeutics

Developing innovative therapeutics that can materially improve the lives of patients

46 Acquired $2.37B

San Diego, United States

Biotechnology Pharmaceutical

Faron

A CLEVER Approach to Fight Cancer.

61 Post-IPO Debt $61.34M

Turku, Finland

Biopharma Biotechnology +1

Promontory Therapeutics

Phase 2 stage biotech company developing novel small-molecule anti-cancer immunotherapies.

15 Series A $72.01M

New York, United States

Biotechnology Life Sciences +1

Lisata Therapeutics, Inc.

Targeted Therapy Delivered

39 Acquired $4.44M

United States

Biotechnology Health and Wellness +1

CytoAgents, Inc

Calming the Cytokine Storm, Rebalancing the Immune System. Accessible treatment for mult...

10 Series A $22.60M

Pittsburgh, United States

Biotechnology Health Care +1

Petra Pharma

Pioneering novel therapies to address cancer and metabolic disorders by targeting essentia...

Debt Financing $75.55M

Biotechnology Health Care +2

About Humanetics Corporation

Humanetics Corporation is a clinical stage pharmaceutical company based in the Minneapolis metropolitan area. The company's lead candidate, BIO 300, is aimed at improving the treatment of solid tumor cancers. BIO 300 serves a dual purpose, sensitizing tumor cells to enhance radiation treatment efficacy, and protecting...

Taxonomy

Pharmaceuticals, Oncology, Medical Countermeasures, Biodefense, COVID-19, Inflammation, Radiation Damage, Clinical Stage, Solid Tumor Cancers, Radiation Modulators, Pulmonary Injury, Acute Radiation Syndrome, Drug Development, Clinical Research, Healthcare Innovation

Frequently Asked Questions

Companies similar to Humanetics Corporation include Aston Sci., Antengene, Aegera Therapeutics Inc., Moleculin Biotech, Inc., Cantex Pharmaceuticals, Inc.. They work in Biotechnology and Pharmaceutical and share Humanetics Corporation's focus on drug development, oncology and pharmaceuticals.

Bounce Watch lists 12 companies that share Humanetics Corporation's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches Humanetics Corporation and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Humanetics Corporation Profile Aston Sci. Alternatives Antengene Alternatives Aegera Therapeutics Inc. Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Humanetics Corporation on 12 Sep 2024. The 12 companies listed here were last checked between 12 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.